An EnvisionTEC 3D-Bioplotter, a world leading bioprinter, has been purchased by the Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois at Urbana-Champaign.
It will be utilised to conduct tissue engineering and regenerative biology research.
The IGB chose the premium model of the bioprinter, which is the Manufacturer Series, that was specifically designed for advanced tissue engineering.
“This platform is going to enable some exciting new research efforts,” said Associate Professor Brendan Harley from the Chemical and Biomolecular Engineering Department and the Leader of the IGB’s Regenerative Biology and Tissue Engineering (RBTE) Theme.
“This bioplotter will facilitate work seeking to regenerate musculoskeletal tissues such as bone and tendon as well as to identify new ways to treat cancer,” he added.
The new 3D-Bioplotter will be placed in a campus facility where researchers can easily access it.
It is considered to be the most advanced out of all of the available 3D-Bioplotter models.
Among its unique features are a temperature-controlled platform that can boost the survival of biologic materials, an Automated Head Exchanger (AHX) with five print heads, and a multi-function HD camera that can record each individual layer of a build project for pre-clinical and clinical research.
“We’re proud to have developed a bioprinter that can be used to provide tissue engineering researchers with all of the controls and tools necessary to develop solutions for a range of healthcare and other issues,” said Jay Murray, Director of MCAD Sales, North America.
A Starter and Developer model is also offered by EnvisionTEC for those who do not need all the control and operations of the premium Manufacturer type.
The 3D-Bioplotter has already been used for research in over 250 medical, scientific and technical research papers published in peer-reviewed journals.